A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
source https://www.sciencedaily.com/releases/2020/12/201209115232.htm
Thursday, 10 December 2020
Related Posts
Unravelling the mystery of brown dwarfsBrown dwarfs are astronomical objects with masses between those of pla… Read More
Breakthrough in sizing nanoparticles using fluid-filled tubesScientists have discovered that the mass and size of nano-particles ca… Read More
Old habit-controlling neurons may also help the brain learn new tricksIn a study of rodents, scientists discovered that a part of the brain … Read More
Observing a higher-dimensional topological state with metamaterialsLinked Weyl surfaces, a novel type of topological phase that exists in… Read More
Carbon neutrality – a new policy brief for municipalities world wideHow to design efficient demo areas for urban carbon sequestration? In … Read More
Climate change challenge: Terminology used by scientists confounds publicA new study finds that U.S. residents struggle to understand terms fre… Read More
0 comments: